[ad_1]
During 2021, however, a new plan was created to speed up new research, turning the idea into a well-funded company that is now Altos. This effort was created under the direction of Richard Klausner, former head of the National Cancer Institute and now an entrepreneur. Klausner, who helped create companies like before Juno Therapeutics and a cancer research company Grail, is known for organizing large and profitable bets on new biotechnologies.
According to a move to Altos Labs in the UK, Klausner is the CEO of the new company. Klausner did not respond to attempts to contact him by email and phone. Like Milner, he also lives in Los Altos Hills.
Numerous startups are looking for reprogramming technology, including Life Biosciences, Turn Biotechnologies, AgeX Therapeutics and Shift Bioscience in the UK, although these efforts have yet to result in proven treatment in people in clinical trials.
“Investors are raising hundreds of millions of dollars to invest in reprogramming, specifically parts that are aimed at rejuvenating parts or the human body,” says David Sinclair, a Harvard University researcher last December. reported using mouse recovery techniques.
Sinclair said the area is “newborn,” but believes it has only one promise. “What else can you do to reverse the age of the body?” he says. “In my lab we are marking the major organs and tissues, such as the skin, muscles and brain, to see which we can rejuvenate.” Sinclair says he is not involved in Altos, but he spoke at the 2020 meeting and asked for an award on the Milky Way.
A science business
Altos has yet to make an official announcement, but this year it has entered Delaware and reporting the values presented in California in June indicates that the company has raised at least $ 270 million, according to Will Gornall University business school professor. British Columbia reviewed the document. In addition to Bezos and Milner, the company may have additional technology-rich figures and capitalist risks as investors.
Other recruitments by Altos include Peter Walter, a laboratory at the University of California, San Francisco, behind a molecule that shows significant effects on memory. Wolf Reik has also joined, a reprogramming specialist after the center recently resigned as director of the Babraham Institute in the UK he said he was taking a job with “another research organization” that was now believed to be Altos. Walter and Reik refused.
At least initially, Altos will fund researchers with no immediate hope for products or revenue. According to a person reported by Klausner and Milner, the company’s initial exit will be “excellent science”.
Altos is attracting university professors by offering salaries of one million dollars or more a year to the sports star, plus equity, with no problem applying for grants. A researcher who has confirmed that Manuel Serrano of the Barcelona (Spain) Biomedical Research Institute in Barcelona (Spain) accepts Altos’ job offer has said that the company will pay him five or ten of what he now earns.
“The philosophy of Altos Labs is to conduct research driven by curiosity. This is what I love to do and do, ”says Serrano, who plans to move to a facility in Cambrose (UK).
Any treatment for a major aging disease can cost billions, but Altos doesn’t count on making money in the beginning. “The goal is to understand rejuvenation,” Serrano says. “I’d say there’s an idea for revenue in the future, but it’s not an immediate goal.”
[ad_2]
Source link
